Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut (FLI), WHO Collaborating Centre for Rabies Surveillance and Research, WOAH Reference Laboratory for Rabies, Greifswald-Insel Riems, Germany.
Institute of International Animal Health/One Health, Friedrich-Loeffler-Institut (FLI), Greifswald-Insel Riems, Germany.
PLoS Negl Trop Dis. 2022 Aug 22;16(8):e0010422. doi: 10.1371/journal.pntd.0010422. eCollection 2022 Aug.
Dog-mediated rabies is responsible for tens of thousands of human deaths annually, and in resource-constrained settings, vaccinating dogs to control the disease at source remains challenging. Currently, rabies elimination efforts rely on mass dog vaccination by the parenteral route. To increase the herd immunity, free-roaming and stray dogs need to be specifically addressed in the vaccination campaigns, with oral rabies vaccination (ORV) of dogs being a possible solution. Using a third-generation vaccine and a standardized egg-flavoured bait, bait uptake and vaccination was assessed under field conditions in Namibia. During this trial, both veterinary staff as well as dog owners expressed their appreciation to this approach of vaccination. Of 1,115 dogs offered a bait, 90% (n = 1,006, 95%CI:91-94) consumed the bait and 72.9% (n = 813, 95%CI:70.2-75.4) of dogs were assessed as being vaccinated by direct observation, while for 11.7% (n = 130, 95%CI:9.9-17.7) the status was recorded as "unkown" and 15.4% (n = 172, 95%CI: 13.4-17.7) were considered as being not vaccinated. Smaller dogs and dogs offered a bait with multiple other dogs had significantly higher vaccination rates, while other factors, e.g. sex, confinement status and time had no influence. The favorable results of this first large-scale field trial further support the strategic integration of ORV into dog rabies control programmes. Given the acceptance of the egg-flavored bait under various settings worldwide, ORV of dogs could become a game-changer in countries, where control strategies using parenteral vaccination alone failed to reach sufficient vaccination coverage in the dog population.
狗介导的狂犬病每年导致数万人死亡,在资源有限的环境中,通过注射为狗接种疫苗以从源头控制疾病仍然具有挑战性。目前,消除狂犬病的努力依赖于通过注射途径大规模为狗接种疫苗。为了提高群体免疫力,需要在疫苗接种活动中特别针对流浪狗和散养狗,对狗进行口服狂犬病疫苗(ORV)接种可能是一种解决方案。在纳米比亚的实地条件下,使用第三代疫苗和标准化的鸡蛋味诱饵,评估了口服疫苗接种的效果。在这项试验中,兽医工作人员和狗主人都对这种疫苗接种方法表示赞赏。在提供给 1115 只狗的诱饵中,90%(n=1006,95%CI:91-94)被狗食用,通过直接观察,72.9%(n=813,95%CI:70.2-75.4)的狗被评估为已接种疫苗,而 11.7%(n=130,95%CI:9.9-17.7)的狗的状态记录为“未知”,15.4%(n=172,95%CI:13.4-17.7)被认为未接种疫苗。体型较小的狗和与多只其他狗一起提供诱饵的狗的接种率显著更高,而其他因素,例如性别、圈养状态和时间则没有影响。这项首次大规模实地试验的良好结果进一步支持了将 ORV 纳入狂犬病控制计划的战略。鉴于在世界各地的各种环境中对鸡蛋味诱饵的接受程度,对狗进行 ORV 可能会成为改变游戏规则的因素,在这些国家,单独使用注射疫苗的控制策略未能在狗群中达到足够的疫苗接种覆盖率。